Skip to content

Deserpidine

Catecholamine-depleting Sympatholytic — CARDIOVASCULAR SYSTEM

Also known as: deserpidin, raunormin, raunormine, recanescin, recanescine, reserpidine

OfmFDA approvedATC C02AA05ATC C02LA03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Deserpidine is an ofm drug in the Catecholamine-depleting Sympatholytic class catalogued in DrugCentral. It was first approved by the FDA in 1957. DrugCentral lists 1 molecular target, including SLC18A2.

  • Approval status: ofm (first approved 1957 by the FDA).
  • Drug class: Catecholamine-depleting Sympatholytic.
  • Molecular targets: SLC18A2 (1 listed in DrugCentral).
  • ATC code: C02AA05 (Rauwolfia alkaloids).
  • Molecular formula: C32H38N2O8; molecular weight 578.66 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Contraindications (26)

  • Acute pancreatitis
  • Anuria
  • Azotemia
  • Cirrhosis of liver
  • Dehydration
  • Diabetes mellitus
  • Disease of liver
  • Fluid volume disorder
  • Gout
  • Hepatic coma
  • Hypercalcemia
  • Hypercholesterolemia
  • Hyperparathyroidism
  • Hypertriglyceridemia
  • Hyperuricemia
  • Hypochloremic alkalosis
  • Hypokalemia
  • Hypomagnesemia
  • Hyponatremia
  • Hypovolemia
  • Impaired renal function disorder
  • Neonatal hyperbilirubinemia
  • Oliguria
  • Secondary angle-closure glaucoma
  • Sympathectomy
  • Systemic lupus erythematosus

Mechanism & targets

Established pharmacologic classCatecholamine-depleting Sympatholytic

Molecular targets (1)

TargetGeneActionActivity
Synaptic vesicular amine transporterSLC18A2inhibitor—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1957-04-19FDA——

ATC classification

ATC codeTherapeutic hierarchy
C02AA05CARDIOVASCULAR SYSTEM › ANTIHYPERTENSIVES › ANTIADRENERGIC AGENTS, CENTRALLY ACTING › Rauwolfia alkaloids
C02LA03CARDIOVASCULAR SYSTEM › ANTIHYPERTENSIVES › ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION › Rauwolfia alkaloids and diuretics in combination

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Deserpidine is on its molecule page.

Molecular formulaC32H38N2O8
Molecular weight578.66 g/mol
CAS number131-01-1
InChIKeyCVBMAZKKCSYWQR-WCGOZPBSSA-N
PubChem CID8550
CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=CC=CC=C45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C1=CC(OC)=C(OC)C(OC)=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Deserpidine work?

Its molecular targets in DrugCentral include SLC18A2 (inhibitor).

When was Deserpidine first approved?

Deserpidine was first approved by the FDA in 1957.

What drug class does Deserpidine belong to?

Deserpidine is in the Catecholamine-depleting Sympatholytic class.

What is the chemical formula of Deserpidine?

Deserpidine has the molecular formula C32H38N2O8 and a molecular weight of 578.66 g/mol.

Browse: all drugs starting with D · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1957-04-19
AgencyFDA
Targets1
Indications0
FormulaC32H38N2O8
DrugCentral ID810
Interactive profile